News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Clarus Lifesciences II, L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/12/2019 |
SC 13D/A
| Clarus Lifesciences II, L.P. reports a 0.3% stake in NanoString Technologies, Inc. |
| 03/22/2019 |
SC 13D/A
| Clarus Lifesciences II, L.P. reports a 6.1% stake in NanoString Technologies, Inc. |
| 07/25/2018 |
SC 13D/A
| Clarus Lifesciences II, L.P. reports a 14% stake in NanoString Technologies, Inc. |
| 04/04/2018 |
SC 13D/A
| Clarus Lifesciences II, L.P. reports a 7% stake in Catabasis Pharmaceuticals, Inc. |
| 02/09/2018 |
SC 13D/A
| Clarus Lifesciences II, L.P. reports a 12% stake in Catabasis Pharmaceuticals, Inc. |
| 06/07/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/13/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 10/04/2016 |
SC 13D/A
| CATABASIS PHARMACEUTICALS INC reports a 15.4% stake in Catabasis Pharmaceuticals, Inc. |
| 03/16/2016 |
SC 13D/A
| Clarus Lifesciences II, L.P. reports a 0% stake in TetraLogic Pharmaceuticals Corporation |
| 02/05/2016 |
SC 13D/A
| Clarus Lifesciences II, L.P. reports a 16% stake in TetraLogic Pharmaceuticals Corporation |
| 08/25/2010 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 01/08/2010 |
SC 13D/A
| Clarus Lifesciences II, L.P. reports a 20.1% stake in Achillion Pharmaceuticals, Inc. |
|
|